Potential role of the geriatric nutritional risk index as a novel risk factor for the development of non-valvular atrial fibrillation in patients with heart failure

被引:1
|
作者
Kaplan, M. [1 ]
Vuruskan, E. [1 ]
Altunbas, G. [1 ]
Yavuz, F. [2 ]
Kaplan, G., I [3 ]
Duzen, I., V [1 ]
Alic, E. [1 ]
Savcilioglu, M. D. [1 ]
Annac, S. [4 ]
Bursa, N. [5 ]
Sucu, N. M. [1 ]
机构
[1] Gaziantep Univ, Dept Cardiol, Sch Med, TR-27100 Gaziantep, Turkey
[2] Adiyaman Univ, Dept Cardiol, Sch Med, Adana, Turkey
[3] Ersin Arslan Training & Res Hosp, Dept Internal Med, Gaziantep, Turkey
[4] Hasan Kalyoncu Univ, Fac Hlth Sci, Gaziantep, Turkey
[5] Hacettepe Univ, Dept Stat, Ankara, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2021年 / 122卷 / 09期
关键词
malnutrition; heart failure; atrial fibrillation; OBESITY PARADOX; OUTCOMES; MORTALITY;
D O I
10.4149/BLL_2021_102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The geriatric nutritional risk index (GNRI) is a simple and objective nutritional assessment tool for elderly patients. Lower GNRI values are associated with a worse prognosis in heart failure with reduced ejection fraction (HFrEF). Our aim is to investigate the relationship between malnutrition and follow-up cardiovascular (CV) events in HFrEF. METHODS: A retrospective study was performed on 362 patients with HFrEF. The baseline GNRI was calculated at the first visit. The patients were divided into three groups according to the GNRI: >98, no-risk group; 92 to <= 98, low risk group; 82 to <92, moderate-to-high-risk group. The study endpoint was a composite of follow-up CV events, including all-cause mortality, non-valvular atrial fibrillation (NVAF) , need for cardioverter defibrillator (ICD) therapy, HfrEF-related hospitalizations and need for percutaneous coronary interventions (PCIs). RESULTS: Follow-up data showed that the group with moderate-to-high risk had a significantly higher incidence of NVAF, PCIs and all-cause mortality compared to other groups (p<0.001, p: 0.026 and p<0.001 respectively). However, hospitalizations and the need for ICD placement were similar as compared between groups (p>0.05). Mean GNRI value was 83.3 in NVAF patients and 101.1 in patients without NVAF (p<0.001). Kaplan Meier survival analysis showed that patients from the group with moderate-to-high risk had a significantly worse survival rate (p < 0.001). In the multivariate Cox regression analysis, the group with moderate-to-high risk (HR =3.872) and ICD implantations (HR = 4.045) were associated with increased mortality. CONCLUSION: The GNRI value may have a potential role for predicting future events, especially NVAF in patients with HfrEF.
引用
收藏
页码:636 / 642
页数:7
相关论文
共 50 条
  • [41] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
    Chang, Kuo-Hsuan
    Chen, Chiung-Mei
    Wang, Chun-Li
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Wu, Hsiu-Chuan
    Chang, Chien-Hung
    Chang, Shang-Hung
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [42] Electrical cardioversion for non-valvular atrial fibrillation - underestimated risk for thromboembolic complications?
    Klein, H. H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (24) : 1309 - 1311
  • [43] Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation
    Le Goff, Laurine
    Demuth, Stanislas
    Fickl, Andreas
    Muresan, Lucian
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2023, 81 (08) : 712 - 719
  • [44] Cardiac troponin I: Prothrombotic risk marker in non-valvular atrial fibrillation
    Providencia, Rui
    Paiva, Luis
    Faustino, Ana
    Botelho, Ana
    Trigo, Joana
    Casalta-Lopes, Joao
    Nascimento, Jose
    Leitao-Marques, Antonio Manuel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 877 - 882
  • [45] Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review
    Pallazola, Vincent A.
    Kapoor, Rishi K.
    Kapoor, Karan
    McEvoy, John W.
    Blumenthal, Roger S.
    Gluckman, Ty J.
    VASCULAR MEDICINE, 2019, 24 (02) : 141 - 152
  • [46] Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation
    Zhao, Yu-Hui
    Zhang, Ting
    Du, Xin
    Wen, Dan
    Shang, Mei-Sheng
    Ma, Chang-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16587 - 16595
  • [47] Anticoagulation Treatment in High-Risk Medicare Advantage Patients with Non-Valvular Atrial Fibrillation
    Bruno, Amanda S.
    Trocio, Jeffrey N.
    Wiederkehr, Daniel
    Abdulsattar, Younos
    Gdovin, Joette
    Brown, Courtney
    Dye, Joseph T.
    Louder, Anthony M.
    Mardekian, Jack
    Pasquale, Margaret
    CIRCULATION, 2014, 130
  • [48] Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
    Kawaji, Tetsuma
    Ogawa, Hisashi
    Hamatani, Yasuhiro
    Kato, Masashi
    Yokomatsu, Takafumi
    Miki, Shinji
    Abe, Mitsuru
    Akao, Masaharu
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (07):
  • [49] NLRP3 Expression and Its Predictive Role in Heart Failure with Preserved Ejection Fraction among Non-Valvular Atrial Fibrillation Patients
    Chen, Shijian
    Yu, Ziheng
    Wen, Wen
    Chen, Jiming
    Lu, Kongjie
    CARDIOLOGY, 2025, 150 (01) : 72 - 78
  • [50] Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation
    Du, He
    Bi, Ke
    Xu, Lisha
    Chen, Feng
    Xiong, Wenfeng
    Wang, Yin
    CARDIOVASCULAR JOURNAL OF AFRICA, 2021, 32 (03) : 116 - 122